Peptide therapy
On the roadmap, not the menu yet.
Recovery and performance peptides are something we are watching closely, but they are not part of the launch.
Why we are waiting.
The rules around compounded peptides are still moving. We would rather add them once we can do it cleanly and safely than rush.
What this means
Watched, not sold
We are tracking the regulatory position and will only add peptide therapy when it can be prescribed and dispensed properly through our clinical and pharmacy partners.
- Not available at launch
- Added only when it can be done cleanly
- Prescribed by licensed clinicians when offered
- Dispensed by licensed pharmacy partners
Evidence
What the evidence says
The evidence for many peptides is still early, and the regulatory position in the US is moving. We would rather wait until a treatment can be prescribed by a clinician and dispensed by a licensed pharmacy than offer it before that is clear.
Evidence-informed and general, not medical advice. A licensed clinician decides what is right for you.
Ready when you are